Takeda Takes Aim At Proposed Generic Drug In New Delaware Patent Case

(October 26, 2016, 12:41 PM EDT) -- WILMINGTON, Del. — An application by Mylan Pharmaceuticals Inc. to market a generic version of the brand-name drug Colcrys would infringe 17 patents, according to a lawsuit filed Oct. 24 in the U.S. District Court for the District of Delaware (Takeda Pharmaceuticals U.S.A. Inc. v. Mylan Pharmaceuticals Inc., No. 16-987, D. Del.)....

Attached Documents

Related Sections